Global Compact Advanced Radiotherapy Systems Market Research Report
- Report Code: CO 1000
- Publish Date: Upcoming
The global compact advance radiotherapy systems market, mainly driven by rapidly changing cancer treatment technology and growing number of cancer patients, was valued at $541 million in 2013, and expected to be $663 million by 2018. It is expected to grow at a CAGR of 4.1%. Compact advance radiotherapy systems are the well accepted medical devices for radiotherapy in different oncology procedures. Though it possesses a small market share in the external beam radiation therapy, the compact advance radiotherapy systems contribute significantly, as far as technological advancement is concerned.
The report ‘Compact Advance Radiotherapy Market forecast, 2012-2018’ analyzes the market of devices by segments, such as Cyberknife, Gamma Knife, and TomoTherapy system. All of these segments are expected to experience a positive growth till 2018, with an increase in cancer patient pool, increased awareness for procedures, and sophisticated diagnostic techniques. With a market value of $262 million and $186 million, Gamma Knife and Cyber Knife segments have been contributing 48% and 34% in terms of the total compact advance radiotherapy devices market respectively. Both the markets have been witnessing maximum growth because of increase in cancer patient pool.
In North America (US, Canada), Europe (Germany, France, Italy, Spain, UK), and Asia (India, China, Japan) the rising rates of cancer population have been driving the market growth. The compact advance radiotherapy system market growth is significantly higher in North America because it is always inclined to the newer techniques, while comparatively slow-moving markets such as Europe and Japan are maturing with both old and new technologies. North America is the most dynamic, highly competitive, and the largest market for Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc., Mevion Medical Systems, Inc. radiotherapy devices globally.
The compact advance radiotherapy system market is still restricted for the developing countries due to the huge installation price involved. It requires highly skilled professionals for its proper application and usage. The major hindrance for these systems has been the widespread usage of other highly efficient medical robotic systems such as da-Vinci robotic system, where no radiation is involved for the treatment. Majorly, the U.S. and Europe comprise the maximum share of the compact advance radiotherapy system market but developing countries, such as the Asian countries and other regions of the world are adopting new policies to welcome this therapeutic procedure in the fight against cancer.
Prevalence of cancer worldwide is around 7.4 million (53%) in males and 6.7 million (47%) in females, giving a male to female ratio of 10:9. In 2012, there were 14.1 million new cases of cancer in the world. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the US. Cancer remains the second most common cause of death in the US, accounting for nearly 1 of every 4 deaths.
Segment and country specific company shares, news & deals, mergers and acquisitions, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed.
Customization Options
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of compact advance radiotherapy system products (segment wise)
- Product matrix which gives a detailed comparison of compact advance radiotherapy system product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the compact advance radiotherapy system products (segment wise and country wise)
- Comprehensive coverage of compact advance radiotherapy system product approvals, pipeline products, and product recalls
Epidemiology Data
- Country specific prevalence of Prostate Cancer, Breast and female genital organs Cancers, Lung and pleura Cancers, Head and neck cancers, Colorectal Cancer, Spine Cancer and Brain Cancer
- Country specific Patient pool of Prostate Cancer, Breast and female genital organs Cancers, Lung and pleura Cancers, Head and neck cancers, Colorectal Cancer, Spine Cancer and Brain Cancer
- Disease progression (pattern analysis)
Procedure Volume Data
- Number of prostate cancer, brain cancer, lung, and head and neck cancers surgeries performed annually in each country tracked till sub-segment level
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of surgeons response to market events and trends
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology data
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Pricing Trends
- Cost analysis of compact advance radiotherapy devices in various countries
- prostate cancer, brain cancer, lung, and head and neck cancers procedural investment in major countries
Competitive Intelligence
- The company share analysis of compact advance radiotherapy devices for the top players of the market in the region
- The crucial developments and strategies of companies inculcating in their portfolio for compact advance radiotherapy devices
Alternative Products: Impact analysis
MMM’s healthcare decision making quadrant is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like Patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and cancer centers, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure).
1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Applications
4.1 Prostate Cancer
4.2 Breast and female genital organs Cancers
4.3 Lung and pleura Cancers
4.4 Head and neck cancers
4.5 Colorectal Cancer
4.6 Spine Cancer
4.7 Brain Cancer
5 By Products
5.1 Cyberknife
5.2 TomoTherapy
5.3 Gamma Knife
6 By Geographies
6.1 North America
6.2 Europe
6.3 Asia
6.4 Rest of World
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Cyberknife Cyberknife and TomoTherapy and Gamma Knife adds up to total |
Upcoming |
|
|
TomoTherapy TomoTherapy and Cyberknife and Gamma Knife adds up to total |
Upcoming |
|
|
Gamma Knife Gamma Knife and Cyberknife and TomoTherapy adds up to total |
Upcoming |
|
|
North American Compact Advanced Radiotherapy Systems Market The North American market for compact advanced radiotherapy systems, mainly driven by rapidly changing cancer treatment technology and growing number of cancer patients, was valued at $246.6 million in 2013 and is expected to reach $281.9 million by 2018, growing at a CAGR of 2.7% during the forecast period. The report analyzes the market under three product segments: CyberKnife, Gamma Knife, and TomoTherapy. Varian Medical Systems, Elekta AB, Accuray Incorporated, Siemens, Ion Beam Applications (IBA) SA, Covidien plc, ProTom International Inc., and Mevion Medical Systems, Inc. are the key players in this market. |
Upcoming |
|
|
European Compact Advanced Radiotherapy Systems Market The European market for compact advanced radiotherapy systems, mainly driven by rapidly changing cancer treatment technology and growing number of cancer patients, was valued at $96.0 million in 2013 and is expected to reach $124.3 million by 2018, growing at a CAGR of 5.3% during the forecast period. The report analyzes the market under three product segments: CyberKnife, Gamma Knife, and TomoTherapy. Varian Medical Systems, Elekta AB, Accuray Incorporated, Siemens, Ion Beam Applications (IBA) SA, Covidien plc, ProTom International Inc., and Mevion Medical Systems, Inc. are the key players in this market. |
Upcoming |
|
|
Asian Compact Advanced Radiotherapy Systems Market The Asian market for compact advanced radiotherapy systems, mainly driven by rapidly changing cancer treatment technology and growing number of cancer patients, was valued at $90.8 million in 2013 and is expected to reach $118.6 million by 2018, growing at a CAGR of 5.5% during the forecast period. The report analyzes the market under three product segments: CyberKnife, Gamma Knife, and TomoTherapy. Varian Medical Systems, Elekta AB, Accuray Incorporated, Siemens, Ion Beam Applications (IBA) SA, Covidien plc, ProTom International Inc., and Mevion Medical Systems, Inc. are the key players in this market. |
Upcoming |
